Tetramethylpyrazine regulates breast cancer cell viability, migration, invasion and apoptosis by affecting the activity of Akt and caspase-3.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Oncology Letters

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ol.2018.7851PMID 29541225PMCID PMC5835919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasion.

  2017cited by this paper
• Efficacy of buparlisib in treating breast cancer

  2017cited by this paper
• Coumestrol Inhibits Proliferation and Migration of Prostate Cancer Cells by Regulating AKT, ERK1/2, and JNK MAPK Cell Signaling Cascades

  2017cited by this paper
• Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

  2017cited by this paper
• Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.

  2016cited by this paper
• Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.

  2016cited by this paper
• The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer

  2016cited by this paper
• An overview of the effective combination therapies for the treatment of breast cancer.

  2016cited by this paper
• Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.

  2016cited by this paper
• AKT in cancer: new molecular insights and advances in drug development

  2016cited by this paper
• Thyroid hormone receptor β1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.

  2016cited by this paper
• New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer.

  2016cited by this paper
• Local and Systemic Therapies for Breast Cancer Patients: Reducing Short-term Symptoms with the Methods of Integrative Medicine

  2015cited by this paper
• CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin.

  2015cited by this paper
• Tetramethylpyrazine inhibits the proliferation of acute lymphocytic leukemia cell lines via decrease in GSK-3β.

  2015cited by this paper
• Tetramethylpyrazine (TMP) exerts antitumor effects by inducing apoptosis and autophagy in hepatocellular carcinoma.

  2015cited by this paper
• Ligustrazine induces apoptosis of breast cancer cells in vitro and in vivo.

  2015cited by this paper
• Involvement of Different networks in mammary gland involution after the pregnancy/lactation cycle: Implications in breast cancer

  2015cited by this paper
• DLJ14, a novel chemo‐sensitization agent, enhances therapeutic effects of adriamycin against MCF‐7/A cells both in vitro and in vivo

  2014cited by this paper
• Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.

  2014cited by this paper
• Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family

  2014cited by this paper
• The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer.

  2014cited by this paper
• Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.

  2013cited by this paper
• Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

  2013cited by this paper
• Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein

  2012cited by this paper
• The natural history of hormone receptor-positive breast cancer: attempting to decipher an intriguing concept.

  2012cited by this paper
• Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis.

  2012cited by this paper
• Tetramethylpyrazine inhibits migration of SKOV3 human ovarian carcinoma cells and decreases the expression of interleukin-8 via the ERK1/2, p38 and AP-1 signaling pathways.

  2011cited by this paper
• Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines.

  2010cited by this paper
• Progress in the pharmacokinetics and clinical pharmacodynamics of tetramethylpyrazine in nervous system

  2010cited by this paper
• Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma.

  2010cited by this paper
• Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells.

  2009cited by this paper
• The effect of tetramethylpyrazine on hydrogen peroxide-induced oxidative damage in human umbilical vein endothelial cells.

  2009cited by this paper
• Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.

  2009cited by this paper
• Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: potential therapeutic application for treatment of gliomas.

  2008cited by this paper
• Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters.

  2006cited by this paper
• Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968 – 2002

  2006cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006cited by this paper
• Molecular mechanisms of caspase regulation during apoptosis

  2004cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Theoretical Biology and Medical Modelling Open Access Targeting Mdm2 by the Small Molecule Rita: towards the Development of New Multi-target Drugs against Cancer Multi-target Drugsritacancer Treatmentblind Dockingmdm2p53 Tumor Suppressor

  year unknowncited by this paper
• Inhibition of tetramethylpyrazine on Pgp , MRP 2 , MRP 3 and MRP 5 in multidrug resistant human hepatocellular carcinoma cells

  year unknowncited by this paper

• Antitumor activity of celecoxib with docetaxel on human triple-negative breast cancer cells

  2025cites this paper
• Traditional Chinese medicine in the treatment of breast Cancer

  2025cites this paper
• Tetramethylpyrazine-Rhein Derivative inhibits the migration of canine inflammatory mammary carcinoma cells by mitochondrial damage-mediated apoptosis and cadherins downregulation.

  2023cites this paper
• The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis

  2023cites this paper
• Promoting Apoptosis, a Promising Way to Treat Breast Cancer With Natural Products: A Comprehensive Review

  2022cites this paper
• Tetramethylpyrazine: A review of the most recent research

  2022cites this paper
• Tetramethylpyrazine inhibits the proliferation, invasiveness and migration of cervical cancer C33A cells by retarding the Hedgehog signaling pathway

  2022cites this paper
• Tetramethylpyrazine induces the release of BDNF from BM‐MSCs through activation of the PI3K/AKT/CREB pathway

  2021cites this paper
• Anticancer activities of TCM and their active components against tumor metastasis.

  2021cites this paper
• The Tetramethylpyrazine Derivative Statmp-151: A Novel Small Molecule Stat3 Inhibitor With Promising Activity Against Breast Cancer

  2021cites this paper
• Tetramethylpyrazine inhibits proliferation of colon cancer cells in vitro

  2021cites this paper
• The combination of two natural medicines, Chuanxiong and Asarum: A review of the chemical constituents and pharmacological activities

  2021cites this paper
• Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction

  2021cites this paper
• Tetramethylpyrazine: A Review of Its Antitumor Potential and Mechanisms

  2021cites this paper
• System Pharmacological Mechanism and Compatibility Laws of Jianghuang from Traditional Chinese Medicine In Blood-Regulating Formulae

  2020cites this paper
• Ligustrazine induces the colorectal cancer cells apoptosis via p53-dependent mitochondrial pathway and cell cycle arrest at the G0/G1 phase.

  2020cites this paper
• Ligustrazine inhibits the viability and motility of colon cancer cells

  2020cites this paper
• Tetramethylpyrazine Induces Apoptosis and Inhibits Proliferation of Hypertrophic Scar-Derived Fibroblasts via Inhibiting the Phosphorylation of AKT

  2020cites this paper
• Effect of Marine Bacillus BC-2 on the Health-Beneficial Ingredients of Flavor Liquor

  2019cites this paper
• Novel Homo-Bivalent and Polyvalent Compounds Based on Ligustrazine and Heterocyclic Ring as Anticancer Agents

  2019cites this paper
• Anti-aging effects exerted by Tetramethylpyrazine enhances self-renewal and neuronal differentiation of rat bMSCs by suppressing NF-kB signaling

  2019cites this paper
• Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer

  2019cites this paper
• Pharmacokinetics and Tissue Distribution of Ligustrazine Phosphate Liposome in Rats

  2018cites this paper